TrialNet Recruitment Platform_Elixir Clinical Research

Elixir Clinical Research realizes the whole-process management of subject

recruitment project with the help of advanced artificial intelligence technology.

Through multi-terminal collaboration and AI empowerment, we build process visualization to achieve patient-centered and excellent clinical trial experience for subjects. Meanwhile, we are committed to protecting the security and privacy of data to ensure the privacy rights of users.

Sponsor

Subjects

Patients who want to join the clinical trial can independently find the clinical trial suitable for themselves and complete the registration with the help of AI.

After AI review, platform staff will recommend suitable patients to the adjacent study sites for interview and informed consent, followed by patients' successful enrollment in the clinical trial.

Whole Process Management For Subject Recruitment Project With AI Empowerment

Multi-terminal Collaboration, Process Visualization, AI Empowerment, Generation Of Statistical Report

Sponsor perspective

Potential patient conditions, de-identified data of enrolled patients, enrollment progress of sites, statistics of reasons for screening failure, project report.

Subject perspective

Overview of the project they joined, matching degree of new drug to their disease (AI calculation), distance from the site, enrollment process and progress.

Site perspective

De-identification of patients' original data, patients' medical history (AI collation), patient interview plan, statistics of enrolled patients.

Data Security And Privacy Protection

The software has passed 3Q qualification and international, national and authoritative third-party information security verification, conforming to international standards, and its user privacy protection protocols are in compliance with regulatory requirements；
All subjects on the TrialNet platform have voluntarily signed up to participate in the clinical trial.

Project Case

Recruitment of patients with solid tumors and hematological diseases

In cooperation with the phase I oncology ward, the platform managed to enroll an average of 50+ patients with solid tumors and 20+ patients with hematological malignancies and lymphoma monthly.
Recruitment cases of patients with chronic diseases such as skin diseases

For the recruitment of patients with psoriasis in the phase III international multicenter study, 30+ patients were enrolled in 20 days outside the hospital；the recruitment was completed 1 month in advance, exceeding the traditional recruitment, and successfully passed the quality audit by the project participator of the foreign enterprise.

In addition, the platform has many patients with chronic diseases such as liver injury, ascites, hypertension, alopecia areata, diabetes, gynecological diseases and Alzheimers' disease who have registered for clinical trials and are distributed all over the country, with a wide range of ages and diverse medication histories. Therefore, the platform can undertake patient recruitment for relevant projects.
Recruitment case of patients with seasonal influenza

For the recruitment of patients with seasonal influenza (non-COVID-19) in the phase III national multicenter study, 62 patients were enrolled in half a month outside the hospital, with a maximum of 11 patients enrolled within a single day, and the recruitment was completed 2.5 months in advance, far exceeding the traditional recruitment.
Recruitment of patients with rare diseases

The platform has currently enrolled patients with rare diseases including muscular dystrophy and Langerhans' cell histiocytosis.